Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance for XIPERE

Bausch + Lomb, along with Clearside Biomedical, a biopharmaceutical company dedicated to developing and delivering treatments that restore and...

Read More

CooperVision Team Expansion Underscores Leadership in Myopia Management and 1 Day Modality

Two key pillars of CooperVision’s industry leadership, its myopia management and 1 Day brand teams, have recently expanded following the hiring of...

Read More

Lucere Dermatology & Laser Clinic Joins FYidoctors

FYidoctors announced Lucere Dermatology & Laser Clinics as the latest esthetic medicine practice to join the growing company The addition...

Read More

New Paper Establishes Context for Myopia Control Axial Length Targets

A new paper that has been accepted for publication in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of...

Read More

Safilo Builds on Its Partnership with Evonik to Introduce TROGAMID® myCX eCO in Lenses

Safilo is building on its 20-year partnership with specialty chemicals world leader Evonik to use their newest high-quality material TROGAMID® myCX...

Read More